An engineered triphasic biomaterial scaffold successfully recreated the cranial suture stem cell niche lost in craniosynostosis, a condition that causes premature fusion of skull bones, according to a July 5 announcement. Using a pore-size-guided "bone-suture-bone" design, the scaffold maintained skeletal stem cells while supporting surrounding bone formation. In mouse models, the construct prevented re-fusion, restored craniofacial growth, and improved skull morphology. The findings may advance regenerative therapies that directly address the underlying causes of pediatric craniofacial disorders.
Craniosynostosis is a congenital condition in which one or more of the fibrous joints between skull bones fuse too early during development. Affecting about one in every 2,500 births, the disorder can restrict normal brain and skull growth, leading to abnormal head shape, elevated intracranial pressure, developmental complications, and repeated surgeries. Current treatments rely on invasive procedures that reopen or reshape the skull; however, many patients experience re-fusion of operated sutures.
A research team led by Professor Yuji Mishina from the Department of Biologic and Materials Science at the University of Michigan School of Dentistry and Dr. W. Benton Swanson from Harvard University's School of Dental Medicine focused on addressing this challenge by targeting the loss of skeletal stem cells within cranial sutures—the biological cause behind craniosynostosis. Rather than simply preventing bone formation, they developed a regenerative strategy to rebuild this stem cell niche itself. Their findings were published in Volume 14 of Bone Research on May 28.
The biodegradable triphasic scaffold was engineered from poly(L-lactic acid), an FDA-approved biomaterial used for various medical applications. Inspired by natural "bone-suture-bone" structures found in human skulls, it contains three interconnected compartments with different pore sizes: a central small-pore region designed to preserve stem cell properties and larger pores on either side promoting vascularization and bone formation.
Experiments showed that skeletal stem cells placed within the central compartment retained their characteristics while differentiating cells migrated into neighboring regions for bone formation. The design also generated patterns resembling natural cranial sutures regarding blood vessel growth and extracellular matrix organization. Lineage-tracing studies demonstrated maintenance of a reservoir for stem cells with their descendants participating in tissue regeneration.
To test resilience against disease-promoting signals such as excessive bone morphogenetic protein activity—linked to abnormal bone formation—the team found that even under these conditions, ossification was resisted within the central compartment and a non-bony niche was preserved.
In mouse models mimicking midline craniosynostosis seen most commonly in humans, after surgical removal of fused sutures followed by implantation with this scaffold instead of conventional treatment resulted in maintained open suture-like tissue with significantly improved craniofacial growth; earlier intervention produced stronger benefits.
"Our goal was not simply to reopen a fused suture but to regenerate the biological niche that allows the skull to grow normally," said Professor Mishina. "By recreating the environment that maintains skeletal stem cells we were able to redirect craniofacial development toward a healthier trajectory." Dr. Swanson added, "This work demonstrates how rational biomaterial design can control stem cell fate and tissue organization simultaneously... We believe principles established here may be broadly applicable beyond craniosynostosis."
